Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
about
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Safety and Efficacy of Novel O ...... on and Valvular Heart Disease.
@en
Safety and Efficacy of Novel O ...... on and Valvular Heart Disease.
@nl
type
label
Safety and Efficacy of Novel O ...... on and Valvular Heart Disease.
@en
Safety and Efficacy of Novel O ...... on and Valvular Heart Disease.
@nl
prefLabel
Safety and Efficacy of Novel O ...... on and Valvular Heart Disease.
@en
Safety and Efficacy of Novel O ...... on and Valvular Heart Disease.
@nl
P2860
P50
P356
P1476
Safety and Efficacy of Novel O ...... on and Valvular Heart Disease.
@en
P2093
Chakradhari Inampudi
Emmanuel Akintoye
P2860
P356
10.1161/JAHA.118.008773
P577
2018-04-05T00:00:00Z